Catherine Lord is distinguished professor of psychiatry and education at the University of California, Los Angeles. She specializes in diagnosis, social and communication development, and intervention in autism.
Catherine Lord
Director, Center for Autism and the Developing Brain
Weill Cornell Medicine
From this contributor
Your questions about the Lancet Commission and ‘profound autism,’ answered
Tony Charman and Catherine Lord answer questions from Spectrum’s webinar on the Lancet Commission’s recommendations for autism research.
Your questions about the Lancet Commission and ‘profound autism,’ answered
By
Spectrum
15 February 2022 | 6 min read
Catherine Lord: Lessons from a storied career in autism research
Catherine Lord's career has been defined by relationships: with mentors, protegees and, above all, with autistic people and their families.
Catherine Lord: Lessons from a storied career in autism research
By
Catherine Lord
3 December 2019 | 6 min read
Measures of success for adults with autism need to mature
As children with autism grow into adults, the challenge is in measuring the skills that matter most in their daily lives.
Measures of success for adults with autism need to mature
By
Catherine Lord
17 November 2015 | 5 min read
Optimal outcome
Some children classified as having autism outgrow their diagnosis, but it’s not yet clear why this group does better, says Cathy Lord.
Autism and the arts: “Lucy” captures disorder‘s complexity
Itʼs not often that movies, books and plays represent science accurately, or with a true and empathetic understanding of its complexity.
Autism and the arts: “Lucy” captures disorder‘s complexity
By
Catherine Lord
28 January 2008 | 5 min read
Explore more from The Transmitter
Novel assembloid illuminates serotonin changes linked to 22q11.2 deletion
The combination of a serotonin-producing organoid with an organoid based on the developing cerebral cortex offers a new way to investigate neuromodulation.
Novel assembloid illuminates serotonin changes linked to 22q11.2 deletion
The combination of a serotonin-producing organoid with an organoid based on the developing cerebral cortex offers a new way to investigate neuromodulation.
By
Sarah DeWeerdt
30 April 2026 | 0 min watch
Reporter’s notebook: Highlights from INSAR 2026
At the 25th annual meeting of the International Society for Autism Research, scientists, clinicians and self-advocates gathered to discuss topics such as autism genetics and the gap between clinical trials and real-world benefits.
Reporter’s notebook: Highlights from INSAR 2026
At the 25th annual meeting of the International Society for Autism Research, scientists, clinicians and self-advocates gathered to discuss topics such as autism genetics and the gap between clinical trials and real-world benefits.
By
Diana Kwon
30 April 2026 | 6 min read
Scientists push back against stricter European Research Council grant application rules
In an open letter, scientists call the ERC’s suggestion to block grant reapplications for an additional year “at odds with scientific excellence.”
Scientists push back against stricter European Research Council grant application rules
In an open letter, scientists call the ERC’s suggestion to block grant reapplications for an additional year “at odds with scientific excellence.”
By
Lauren Schenkman
29 April 2026 | 5 min read